Procedure

Extrapleural pneumonectomy for malignant pleural mesothelioma

^a Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115 and Department of Surgery, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA
^b Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115 and Instructor in Surgery, Department of Surgery, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
^c Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115 and The Richard E. Wilson Professor of Surgical Oncology, Department of Surgery, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115 and Phillip E. Lowe Senior Surgeon, Department of Surgical Services, Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA

^* Corresponding author: ^* Tel.: +1-617-732 5527; fax: +1-617-566-6434. E-mail: dsugarbaker{at}partners.org

Extrapleural pneumonectomy was introduced in the 1940s for the treatment of extensive infections of the lung and pleural space. Over the past 20 years, the extrapleural pneumonectomy technique has been modified and applied to the treatment of locally advanced malignant pleural mesothelioma, achieving substantial reductions in mortality. The current mortality rate of 3.4% at the Brigham and Women's Hospital has permitted us to expand our use of this operation to treat locally advanced lung cancer and thymoma. The extrapleural pneumonectomy technique consists of five basic steps: (1) Incision and exposure of the parietal pleura: (2) Dissection of the tumor and parietal pleura from the chest wall, diaphragm, and mediastinum: (3) Division and control of the pulmonary vessels and bronchus followed by lymph node dissection: (4) En bloc resection of the lung, pleura, pericardium, and diaphragm; (5) Reconstruction of the diaphragm and pericardium. Extrapleural pneumonectomy is a complex and challenging operation. Accompanied by a 60% minor and major complication rate, it requires a unique management approach to achieve 3.4% mortality. Primary contributing factors to the reduction in mortality include a reduced operative time of 3 h, refinements in operative technique, and improved selection of patients. The technique discussed below is the culmination of 20 years' experience with malignant pleural mesothelioma at the Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA USA.

Key Words: Malignant pleural mesothelioma • Extrapleural pneumonectomy • Technique